Last reviewed · How we verify
Nescafé Gold Blend (exposed) — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Nescafé Gold Blend (exposed) (Nescafé Gold Blend (exposed)) — The Danish Epdiemiology Science Centre.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Nescafé Gold Blend (exposed) TARGET | Nescafé Gold Blend (exposed) | The Danish Epdiemiology Science Centre | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Nescafé Gold Blend (exposed) CI watch — RSS
- Nescafé Gold Blend (exposed) CI watch — Atom
- Nescafé Gold Blend (exposed) CI watch — JSON
- Nescafé Gold Blend (exposed) alone — RSS
Cite this brief
Drug Landscape (2026). Nescafé Gold Blend (exposed) — Competitive Intelligence Brief. https://druglandscape.com/ci/nescaf-gold-blend-exposed. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab